Search results
J&J to acquire experimental eczema drug for $1.25B
NJBIZ· 5 days agoJohnson & Johnson plans to pay $1.25 billion for the rights to an experimental eczema treatment. The New Brunswick-based pharma giant announced the...
Topical Steroid Withdrawal Is As Serious As It Sounds
PopSugar· 6 days agoIf you're on the skin-care side of TikTok, you may have seen videos about topical steroid...
Why a Little Bit of Dirt May Be Healthy for You
Mercola· 2 days agoOne key to a healthy immune system, a lower rate of allergies and a better mood might be getting dirty. The dirt I’m talking about is in the garden, or your pots if you live in an apartment.
Tapinarof Cream Effective For AD, Down to Age 2 Years
Medscape· 7 days agoResults from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old.
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via Yahoo News· 5 days agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
Why ear wax color is a concern for your health
Rolling Out· 6 days agoEar wax, also known as cerumen, is a natural substance produced by glands in the ear canal. While it often goes unnoticed, the color and consistency of...
Introducing peanut butter during infancy can help protect against a peanut allergy later on, new...
7 News Miami· 7 days agoCompared with avoiding peanuts,starting peanut consumption in infancy – as early as around 4 months...
Smart Bandages That Heal Wounds Faster and Talk to Your Doctor Are on the Way
The Wall Street Journal· 6 days agoThe bandage isn’t yet in animal trials. Smart bandages might even go beyond wounds. The Southampton...
New study suggests feeding infants peanut butter can lower allergy risk
Billings Gazette· 3 days agoNearly 33% of adults and more than 25% of children in the United States have at least one allergy. When it comes to peanuts, the allergy can be deadly. A
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
Morningstar· 5 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion ...